Alzheimer's Disease Research

Alzheimer's disease (AD), the most common type of dementia, is an irreversible and progressive neurodegenerative disorder causing cognitive and functional impairment. It is characterized by formation of protein aggregates and progressive loss of neurons in the central nervous system (CNS). The symptoms of AD include short-term memory loss, confusion, irritability, aggression and mood swings, progressing to long-term memory deficit, withdrawal from social interactions and subsequently a loss in higher central functioning.

Alzheimer's Disease Research Products Targets

Products for Alzheimer's Disease Research - Page 21

  1. Cat.No. Product Name Information/Activity
  2. BCC5862 Nogo-66 (1-40) 475221-20-6 Nogo-66 (1-40) chemical structure
  3. BCC7943 ONO 2506 Arundic acid (ONO-2506) is an astrocyte-modulating agent, which delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis. Arundic acid (ONO-2506) has been developed as a therapeutic agent for stroke and Alzheimer’s disease. ONO 2506 chemical structure
  4. BCC5920 PLP (139-151) [SER140]-PLP(139-151) is a fragment of myelin proteolipid protein. PLP (139-151) chemical structure
  5. BCC6027 Prion Protein 106-126 (human) 148439-49-0 Prion Protein 106-126 (human) chemical structure
  6. BCC5999 TCS PrP Inhibitor 13 34320-83-7 TCS PrP Inhibitor 13 chemical structure
  7. BCC7995 2-MPPA 254737-29-6 2-MPPA chemical structure
  8. BCC1327 Acamprosate calcium Acamprosate calcium(Campral EC) is a GABA receptor agonist and modulator of glutamatergic systems; reduces alcohol consumption in animal models of alcohol addiction. Acamprosate calcium chemical structure
  9. BCC6634 N-Acetylglycyl-D-glutamic acid 135701-69-8 N-Acetylglycyl-D-glutamic acid chemical structure
  10. BCC6612 L-AP6 78944-89-5 L-AP6 chemical structure
  11. BCC7400 L-BMAA hydrochloride 16012-55-8 L-BMAA hydrochloride chemical structure

Items 201 to 210 of 399 total